The Future of Female Longevity
From lifespan to healthspan: the investment case for women’s health and longevity
This newsletter is free. But it takes hours each week to research, write, and produce at this level. Here are 5 ways to support my work: 1. click “❤️” to amplify 2. subscribe 3. share this publication 4. buy me coffee 5. become a partner
Connect and collaborate with me here! Email | LinkedIn | Instagram
It’s a quiet truth whispered in both boardrooms and exam rooms: we are living longer, but not necessarily better.
For families, longevity is not an abstract concept. It shows up in very human ways.
The mother who begins to lose her memory too soon
The father slowed by preventable disease
The grandmother who lives long enough to see her great-grandchildren, but not in the health she deserves.
These stories carry both an emotional weight and a financial one. Cognitive decline, chronic illness, and long-term care are not just medical events. They are turning points for families, reshaping legacies, relationships, and balance sheets all at once.
And here is the blind spot: while breakthroughs in technology are emerging that could transform women’s health and longevity, they remain underfunded, under-integrated, and often misunderstood.
New Here?
If you are an investor, operator, or women’s health advocate, start here.
→ Preorder the book: The Billion Dollar Blind Spot
→ Subscribe to the podcast: Blindspot Capital
The Opportunity in Female Longevity Tech
Diagnostics that detect diseases earlier in women. AI-driven imaging that addresses gaps in cardiovascular health. Precision hormone therapies that could redefine midlife and aging. Preventive tools that reduce dementia risk long before symptoms appear.
These are not niche advances. They are the very technologies that will determine whether additional years of life are lived with clarity, independence, and dignity or spent in decline.
For families, the implications are deeply personal. For advisors and investors, they are structural. And for both, the moment to act is now.
Where Health Meets Wealth
This is why I am honoured to be speaking at the SIP Global Health Conference this September at Plaisterers’ Hall in London.
On the Health Tech 2030: What’s Next in Medical Innovation panel, I will present the investment thesis on the technologies set to transform the future of female longevity, and why families, their advisors, and investors must pay attention now.
Because this conversation is not only about markets or medicine. It is about how we safeguard the health, agency, and dignity of the people we love and ensure that the wealth we pass on truly enhances their lives.
What We’ll Explore
The innovations reshaping women’s health and longevity over the next decade.
Why female longevity remains one of the most mispriced opportunities in health innovation.
How families and advisors can prepare for both the risks and the promise of longer lives.
❤️ Enjoying this? If this post sparked something for you, click the ❤️ at the bottom. It helps more than you know and tells me you're reading.
An Invitation
If you are in London on 25 September 2025, I would love for you to join us in the room.
As part of my community, I can share an exclusive registration link with a preferred rate, a way of opening the doors to a conversation that is usually reserved for only the most forward-looking families and advisors. Use code MUS-SIP30 at checkout.
Because in the end, this isn’t just about innovation. It’s about the legacies we leave. Measured not only in assets preserved, but in health, clarity, and purpose carried across generations.
Pre-order my upcoming book The Billion Dollar Blind Spot to learn why women’s health is the future of healthcare investing.
Join Our Network
Are you building or backing credible, under-the-radar solutions in women’s health?
We want to hear from you. Reach out privately or reply to this post. FHV curates brands and breakthroughs that deserve broader attention in the women’s health ecosystem.
I write weekly at FemmeHealth Ventures Alliance about capital, care, and the future of overlooked markets. If you are building, backing, or allocating in this space, I’d love to connect.
Disclaimer & Disclosure
This content is for informational and educational purposes only. It does not constitute financial, investment, legal, or medical advice, or an offer to buy or sell any securities. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making investment decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.